The Masonic Cancer Center creates a collaborative research environment focused on the causes, prevention, detection, and treatment of cancer; applying that knowledge to improve quality of life for patients and survivors; and sharing its discoveries with other scientists, students, professionals, and the community. Founded in 1991, the cancer center became a National Cancer Institute-designated comprehensive cancer center in 1998, one of only 45 institutions in the United States and two in Minnesota to hold that designation.
More than 500 faculty and staff are members of the Masonic Cancer Center. It is home to some of the world's top cancer researchers in bone marrow transplantation, breast cancer, bone cancer, cancer genetics, tobacco research, immunology, new therapies development, pediatric oncology, chemoprevention, and epidemiology.
- The Cancer Information Line 612-624-2620 that is staffed from 8 a.m. to 4:30 p.m. Monday through Friday by a cancer nurse.
News and Events
Register for the Third Minnesota Neuro-Oncology Symposium
The Masonic Cancer Center invites you to register for the Third Minnesota Neuro-Oncology Symposium scheduled for May 9-10, 2015 at the Hyatt Regency Hotel in downtown Minneapolis. The symposium, which is presented by the center's Brain Tumor Translational Working Group and the University of Minnesota's Department of Pediatrics, will discuss current and developing therapies for brain and nervous system tumors. For more information visit the website.
Exploring immune agents in breast cancer
Douglas Yee, M.D., director of the Masonic Cancer Center at the University of Minnesota and a HemOnc Today Editorial Board member, discusses the advances in immune-based therapies in breast cancer. View the video.